Hashimoto-Enzephalopathie – steroid-sensitive Enzephalopathie

J. Unger; N. Bergemann; M. Schwaninger

doi:10.1055/s-0038-1626870

Nervenheilkunde, Table of Contents

Nervenheilkunde 2007; 26(05): 357-361
DOI: 10.1055/s-0038-1626870

Original Article

Schattauer GmbH

Hashimoto-Enzephalopathie – steroid-sensitive Enzephalopathie

Eine neuropsychiatrische HerausforderungHashimoto encephalopathy – steroid-responsive encephalopathy associated with autoimmune thyroiditisa neuropsychiatric challenge

Authors

J. Unger

¹Zentrum für Psychosoziale Medizin, Klinik für Allgemeine Psychiatrie, Heidelberg (Direktor: Prof. Dr. Ch. Mundt)
N. Bergemann

¹Zentrum für Psychosoziale Medizin, Klinik für Allgemeine Psychiatrie, Heidelberg (Direktor: Prof. Dr. Ch. Mundt)
M. Schwaninger

²Neurologische Universitätsklinik Heidelberg (Direktor: Prof. Dr. W. Hacke)

Abstract

Zusammenfassung

Die Hashimoto-Enzephalopathie ist eine gut behandelbare, steroid-sensitive Enzephalopathie, die sich durch eine Assoziation mit einer Autoimmun-Thyreoiditis (Hashimoto-Thyreoiditis) auszeichnet. Bis jetzt wurden ca. 110 Fallbeschreibungen der Hashimoto-Enzephalopathie in allen Altersgruppen berichtet. Unklarheit besteht über die zugrunde liegenden pathogenetischen Mechanismen. Es können zwei charakteristische Verläufe mit im Vordergrund stehenden neurologischen und psychiatrischen Symptomen unterschieden werden: eine schleichend progrediente Variante und eine akute vaskulitische Form. Trotz unterschiedlicher klinischer Präsentation findet sich generell ein gutes Ansprechen auf eine immunsuppressive Therapie. Bei konsequenter Behandlung ist von einer guten Prognose auszugehen. Im Rahmen des aktuellen Überblicks gehen wir unter anderem auf die zur Zeit diskutierten Ätiologiemodelle, die diagnostischen Standards und die empfohlenen Therapieschemata ein. Differenzialdiagnostische und differenzialtherapeutische Konsequenzen werden diskutiert.

Summary

Hashimoto`s encephalopathy is a steroid-responsive encephalopathy which accompanies an autoimmune thyroiditis (Hashimoto’s thyroiditis). Up to now about 110 cases in all age groups have been reported. The pathogenetic mechanism of the disease remains still unclear. Two characteristically courses with psychiatric and neurological symptoms are distinguished: an insidious diffuse progressive type and a more acute vasculitic type. Despite different clinical presentation an over all excellent response to immunosuppressive therapy was demonstrated. In this overview we summarise the recently discussed etiological models, the diagnostic hallmarks and the suggested therapeutic algorithm. Diffential-diagnostic and differential-therapeutic implications are discussed.

Schlüsselwörter

Hashimoto-Enzephalopathie - steroid-sensitive Enzephalopathie - neuropsychiatrisches Syndrom

Keywords

Hashimoto´s encephalopathy - steroid responsive encephalopathy associated with Hashimoto´s thyroiditis (SREHT) - steroid responsive encephalopathy associated with autoimmune thyroiditis (SREAT) - neuropsychiatric syndrome

Full Text

References

Literatur
1 Brain L, Jellinek EH, Ball K. Hashimoto´s disease and encephalopathy. Lancet 1966; 02: 512-514.
2 Chong JY, Rowland LP, Utiger RD. Hashimoto encephalopathy: syndrom or myth?. Arch Neurol 2003; 60: 164-171.
3 Hartmann M, Schaner B, Scheglmann K, Bücking A, Pfister R. Hashimoto-Enzephalopathie. Steroid-sensitive Enzephalopathie bei Hashimoto-Thyreoiditis. Nervenarzt 2000; 71: 489-494.
4 Taylor SE, Garalda ME, Tudor-Williams G, Martinez-Alier N. An organic cause of neuropsychiatric illness in adolescence. Lancet 2003; 361: 572.
5 Mahmud FH, Lteif AN, Renaud DL, Reed AM, Brands CK. Steroid-responsive encephalopathy associated with Hashimoto’s thyroiditis in an adolescent with chronic hallucinations and depression: case report and review. Pediatrics Sep 2003; 112: 686-690.
6 v. Maydell B, Kopp M, v. Komorowski G, Joe A, Juengling FD, Korinthenberg R. Hashimoto encephalopathy– is it underdiagnosed in pediatric patients?. Neuropediatrics 2002; 33: 86-89.
7 Watemberg N, Willis D, Pellock JM. Encephalopathy as the presenting symptom of Hashimoto´s thyroiditis. J Child Neurol 2000; 15: 66-69.
8 Castillo P, Woodruff B, Caselli R. et al. Steriod-responsive encephalopathy associated with autoimmune thyroidits. Arch Neurol 2006; 63: 197-202.
9 Kothbauer-Margreiter I, Sturzenegger M, Komor J, Baumgartner R, Hess CW. Encephalopathy associated with Hashimoto thyroiditis: diagnosis and treatment. J Neurol 1996; 243: 585-593.
10 Peschen-Rosin R, Schabet M, Dichgans J. Manifestion of Hashimoto´s encephalopathy years before onset of thyroid disease. Eur Neurol 1999; 41: 79-84.
11 Canton A, de Fabregas O, Tintore M, Mesa J, Codina A, Simo R. Encephalopathy associated to autoimmune thyroid disease: more appropriate term for an underestimated condition?. J Neurol Sci 2000; 176: 65-69.
12 Marshall GA, Doyle JJ. Long-Term Treatment of Hashimoto´s Encephalopathy. J Neuropsychiatry Clin Neurosci 2006; 18 (01) 14-20.
13 Shaw PJ WT, Newman PK, Cleland PG, Cartlidge NEF. Hashimoto´s encephalopathy: a steroid-responsive disorder associated with high anti-thyroid antibody titers - report of5 cases. Neurology 1991; 41: 228-233.
14 Forchetti CM, Katsamakis G, Garron DC. Autoimmune thyroiditis and a rapidly progressive dementia: Global hypoperfusion on SPECT scanning suggests a possible mechanism. Neurology 1997; 49: 623-626.
15 Latinville D, Bernardi O, Cougoule JP. et al. Thyriodite d´Hashimoto et encephalopatie myoclonique: hypothesese pathogeniques. Rev Neurol 1985; 141: 55-58.
16 Nolte KW, Unbehaun A, Sieker H, Kloss TM, Paulus W. Hashimoto encephalopathy: a brainstem vasculitis?. Neurology 2000; 54: 769-770.
17 Duffey P, Yee S, Reid IN. et al. Hashimoto´s encephalopathy: a brainstem vasculitis?. Neurol 2000; 54: 769-770.
18 Shibata N, Yamamoto Y, Sunami N, Suga M, Yamashita Y. Isolated angiitis of the CNS associated with Hashimoto´s disease. Rinsho Shinkeigaku 1992; 32: 191-198.
19 Chaudhuri A, Behan PO. The clinical spectrum, diagnosis, pathogenesis and treatment of hashimoto´s encephalopathy (recurrent acute disseminated encephalomyelitis). Curr Med Chem 2003; 10: 1945-1953.
20 Ishii K, Hayashi A, Tamaoka A. et al. Thyrotropinreleasing hormone-induced myoclonus and tremor in a patient with Hashimoto´s encephalopathy. Am J Med Sci 1995; 310: 202-205.
21 Oide T, Tokuda T, Yazaki M. et al. Anti-neuronal autoantibody in Hashimoto´s encephalopathy. Neuropathological, immunhistochemical, and biochemical analysis of two patients. J Neurol Sci 2004; 217: 7-12.
22 Shein M, Apter A, Dickerman Z, Tyano S, Gadoth N. Encephalopathy in compensated Hashimoto thyroiditis: a clinical expression of autoimmune cerebral vasculitis. Brain Dev 1986; 08: 60-64.
23 Laske C, Leyhe T, Buchkremer G, Wormstall H. Depression bei Hashimoto-Enzephalopathie. Erfolgreiche Behandlung einer schweren depressiven Episode mit einem Kortikosteroid als Add-on Therapie. Nervenarzt 2005; 76: 617-622.
24 Rolland F, Chevrollier JP. Depression, anti-thyroid antibodies and Hashimoto encephalopathy. Encephale 2001; 27: 137-142.
25 Archambeaud F, Galinat S, Regouby Y. et al. Hashimoto encephalopathy. Analysis of four case reports. Rev Med Interne 2001; 22: 653-659.
26 Seipelt M, Zerr I, Nau R. et al. Hashimoto´s encephalitis as a differential diagnosis of Creutzfeld-Jakob disease. J Neurol Neurosurg Psychiatry 1999; 66: 172-176.
27 Thorlacius S, Aarli JA, Riise T, Matre R, Johnsen HJ. Associated disorders in myastenia gravis: autoimmune diseases and their relation to thymectomy. Acta Neurol Scand 1989; 80: 290-295.
28 Ferracci F, Moretto G, Candeago RM. et al. Antithyroid antibodies in the CSF. Their role in the pathogenesis of Hashimoto´s encephalopathy. Neurology 2003; 60: 712-714.
29 Ferracci F, Bertiato G, Moretto G. Hashimoto´s encephalopathy: epidemiologic data and pathogenetic considerations. J Neurol Sci 2004; 217: 165-168.
30 Henchey R, Cibula J, Helveston W, Malone J, Gilmore RL. Encephalographic findings in Hashimoto´s encephalopathy. Neurology 1995; 45: 977-981.
31 Schauble B, Castillo PR, Boeve BF, Westmoreland BF. EEG findings in steroid-responsive encephalopathy associated with autoimmune thyroiditis. Clin Neurophysiol 2003; 114: 32-37.
32 Bohnen NI, Parnell KJ, Harper CM. Reversible MRI findings in a patient with Hashimoto´s encephalopathy. Neurology 1997; 49: 246-247.
33 Zettinig G, Asenbaum S, Fueger BJ. et al. Increased prevalence of sublinical brain perfusion abnormalities in patients with autoimmune thyroiditis: evidence of Hashimoto’s encephalitis?. Clin Endocrinol 2003; 59: 637-643.
34 Becker H, Hofmann M, von Einsiedel H, Conrad B, Sander D. Umschriebene Vaskulitis mit Posteriorinfarkt bei Hashimoto-Enzephalopathie. Nervenarzt 2002; 73: 376-379.
35 Flynn SD, Nishiyama RH, Bigos ST. Autoimmune thyroid disease: immunological, pathological and clinical aspects. Crit Rev Clin Lab Sci 1988; 26: 43-94.
36 Vasconcellos E, Pina-Garza JE, Fakhoury T. et al. Pediatric manifestations of hashimoto´s encephalopathy. Pediatr Neurol 1999; 20: 394-398.
37 Galluzi S, Geroldi C, Zanetti O. et al. Hashimoto´s encephalopathy in the elderly: relationship to cognitive impairment. J Geriatr Psychiatry Neurol 2002; 15: 175-179.
38 Dayan CM, Daniels GH. Chronic autoimmune thyroidits. N Engl J Med 1996; 335: 99-107.
39 Hussain NS, Rumbaugh J, Kerr D, Nath A, Hillis AE. Effects of prednisone and plasma exchange on cognitive impairment in Hashimoto encephalopathy. Neurology 2005; 64: 165-166.